Ligand Pharmaceuticals (LGND)

Add to Watchlists
Create an Alert
89.67 +0.44  +0.49% NASDAQ May 22, 8:00PM Delayed 2m USD
View Full Chart
LGND Price Chart
View All Events

LGND Events

Date Type Description
04/24/2015 Misc Ligand Pharmaceuticals Inc 2014 AGM
02/09/2015 09:00 EST Misc Ligand Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2014
02/09/2015 Earnings Ligand Pharmaceuticals Inc Fourth Quarter Earnings in 2014 Release
11/18/2014 10:00 EDT Misc Ligand Analyst Day
10/27/2014 09:00 EDT Misc Q3 2014 Ligand Earnings Conference Call
10/27/2014 Earnings Q3 2014 Ligand Earnings Results
08/04/2014 09:00 EDT Misc Q2 2014 Ligand Pharmaceuticals Inc Earnings Conference Call
08/04/2014 Earnings Q2 2014 Ligand Pharmaceuticals Inc Earnings Results
06/04/2014 Misc Annual General Meeting for Ligand Pharmaceuticals Inc
View All Performance Charts

LGND Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ligand Pharmaceuticals is up 37.76% over the last year vs S&P 500 Total Return up 14.64%, Metabasis Therapeutics up 714.3%, and Amgen up 45.12%.

PDF Report for LGND

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download LGND Pro Report PDF
Advertisement

LGND Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.ligand.com
  • IR Website: http://investor.ligand.com/Investors/Investor-Overview/default.aspx
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Ligand Pharmaceuticals Inc is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.

LGND Excel Add-In Codes

  • Name: =YCI("LGND","name")
  • Description: =YCI("LGND","description")
  • Sector: =YCI("LGND","sector")
  • Industry: =YCI("LGND","industry")
  • Est. Current Fiscal Year End: =YCI("LGND","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.